ArticleOncotarget2015

PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.

Christine Levesque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.